InsidersTradesSigma
Solara Active Pharma Sciences Limited: insider trades · India · SEBI (PIT + SAST)
SEBI:solara-active-pharma-sciences-limitedIN·SEBI (PIT + SAST)Mcap 21.6Bn€
Discover the full insider trade history of Solara Active Pharma Sciences Limited, a listed equity based in India. Shares are listed on IN IN, under the authority of SEBI (PIT + SAST). Market capitalisation: €21.6bn. The latest transaction was filed on 30 June 2025 — Sale. Among the most active insiders: PRONOMZ VENTURES LLP. The full history is free.
128
Insider Decl.
0
Thresholds
€32m
54 ops.
Buy Volume
€33m
37 ops.
Sell Volume
Financial data
FY ended March 2025 · cache
561.35 €
Income statement
Revenue12.41 Bn€
Gross profit5.96 Bn€48% margin
Net income5.4 M€0.0% margin
Balance sheet & cash
Market cap21.62 Bn€
Total debt7.96 Bn€
Free Cash Flow1.73 Bn€
Last declaration on 30 June 2025
Declarations128 total
Executives●Sale0SEBI
€62,50610,000 shares@ €6.2506
Equity Shares
SEBI:ff2dc55f3d9f098f4c64342195b6cfd793016690·
Executives●Sale0SEBI
€29,3814,823 shares@ €6.0919
Equity Shares
SEBI:0b44020e56585aa40e0a98f5bc6ad6ebbf351807·
Executives●Purchase0SEBI
€29,6435,473 shares@ €5.4163
Equity Shares
SEBI:441863af962181f182cdbc139ca4cf44103f2a4f·
Ideal exit: 20 Mar 2026 (T+270)
Executives●Purchase0SEBI
€10m2,000,000 shares@ €4.9881
Equity Shares
SEBI:5561d107e3fe7dd13f76ee9c109e8a5b27525840·
Ideal exit: 13 Mar 2026 (T+270)
Executives●Purchase0SEBI
€4,8291,000 shares@ €4.8285
Equity Shares
SEBI:e955b8d23055a96fa9dd6e37a0bdad34c94ef96e·
Ideal exit: 1 Mar 2026 (T+270)
Executives●Purchase0SEBI
€5,2771,000 shares@ €5.2771
Equity Shares
SEBI:0be526db765cdbd6ffe4a9b2462b8c2b807e482a·
Ideal exit: 6 Dec 2025 (T+270)
Executives●Purchase0SEBI
€69,07213,600 shares@ €5.0788
Equity Shares
SEBI:e1ad745abe82593cdeaba2d104222b6efe00dc2e·
Ideal exit: 25 Nov 2025 (T+270)
Executives●Purchase0SEBI
€1m216,361 shares@ €5.2121
Equity Shares
SEBI:4e8531ceb8d5ff051835eadf0ce5d4bbaa27eebc·
Ideal exit: 18 Nov 2025 (T+270)
Executives●Purchase0SEBI
€788,214152,156 shares@ €5.1803
Equity Shares
SEBI:d3a8c35cc12c55a8191c49cf0b7be5b830346d91·
Ideal exit: 21 Nov 2025 (T+270)
Executives●Purchase0SEBI
€198,49734,000 shares@ €5.8381
Equity Shares
SEBI:a08383d14706782236e2d1d987fb08bdcfd027f7·
Ideal exit: 1 Nov 2025 (T+270)
Executives●Purchase0SEBI
€447,38578,000 shares@ €5.7357
Equity Shares
SEBI:d72d96c029d773987f18813d7ce4dc93cfbe7bc3·
Ideal exit: 29 Oct 2025 (T+270)
Executives●Purchase0SEBI
€26,0293,000 shares@ €8.6763
Equity Shares
SEBI:fa2de213b38db8d5e280197aa4625831567fece5·
Ideal exit: 22 Jun 2025 (T+270)
Executives●Sale0SEBI
€7m2,013,747 shares@ €3.7049
Equity Shares
SEBI:48d4ed0af834f2ba94d1f7efa6a4c6096cdae8b6·
Executives●Sale0SEBI
€342,45192,228 shares@ €3.7131
Equity Shares
SEBI:72e9d64b5e3aa53cb2b6753c145511be0f239935·
Executives●Sale0SEBI
€132,48635,591 shares@ €3.7225
Equity Shares
SEBI:99957a4b0cde3632981550f76e847462c1151252·
Executives●Sale0SEBI
€1m272,181 shares@ €3.7125
Equity Shares
SEBI:a03ce07710d9c4c5a2d1411e82d50a3c49503e3c·
Executives●Sale0SEBI
€3m736,253 shares@ €4.091
Equity Shares
SEBI:9121408c8c9b780454de0d67a2535319cec93be6·
Executives●Sale0SEBI
€2,043500 shares@ €4.0862
Equity Shares
SEBI:e1cf4722c25a7549179aa4900b7f15effaafb34c·
Executives●Sale0SEBI
€822,083200,000 shares@ €4.1104
Equity Shares
SEBI:3f978b617cbd34e7d7de336b223052436d9403df·
Executives●Sale0SEBI
€831,812200,000 shares@ €4.1591
Equity Shares
SEBI:c0e8417d90df40135b275b093ed831797c2f5151·
Executives●Sale0SEBI
€12,4143,000 shares@ €4.138
Equity Shares
SEBI:e614908ab6fcefc1655b16d3c491a46e87142548·
Executives●Sale0SEBI
€815,944200,000 shares@ €4.0797
Equity Shares
SEBI:60a31ba25b894327d167b9779b5c0d76c7ca45cc·
Executives●Sale0SEBI
€412100 shares@ €4.1203
Equity Shares
SEBI:058bec8b598aefa62ad7086b5aaddf1d6d6e86fc·
Executives●Sale0SEBI
€60,92114,826 shares@ €4.1091
Equity Shares
SEBI:c45c21f5c155196665188c3997a7a32fb605aaf7·
Executives●Sale0SEBI
€56,12713,625 shares@ €4.1194
Equity Shares
SEBI:df2a50d042518004dbe1f1362b3e63af0efab4c7·
25 of 128 declarations